PSAP and neoplasm: Some of the identified proteins have been shown to inhibit apoptosis or cause tumor cells to adapt to hypoxia, thereby promoting tumor cell survival, including clusterin [41], CD5L [31], HYOU1 [55], prosaposin [1], and hepatocyte growth factor activator [9].